Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Universal Biosensors Inc (UBI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Universal Biosensors Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1279695.
Total stock buying since 2014: $29,231,366,539.
Total stock sales since 2014: $5,904,743.
Total stock option exercises since 2014: $282,357.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 31,927,899 | $4,782,332 | 0 | $0 | 1,364,666 | $272,933 |
| 2023 | 195,983 | $38,125 | 0 | $0 | 0 | $0 |
| 2022 | 32,297,237 | $13,666,850 | 0 | $0 | 0 | $0 |
| 2021 | 1,378,757 | $1,015,654 | 12,559,109 | $0 | 40,000 | $0 |
| 2020 | 3,900,274 | $1,108,897 | 23,820,765 | $5,240,568 | 40,000 | $0 |
| 2019 | 6,783,133 | $1,311,898 | 3,439,866 | $619,175 | 308,334 | $0 |
| 2018 | 2,754,159 | $607,184 | 0 | $0 | 50,000 | $0 |
| 2017 | 8,505,794 | $2,649,992 | 0 | $0 | 108,334 | $0 |
| 2016 | 382,156 | $112,271 | 0 | $0 | 0 | $0 |
| 2015 | 269,088 | $26,858,364,836 | 100,000 | $45,000 | 36,248 | $9,424 |
| 2014 | 260,000 | $2,347,708,500 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-05 | 30,927,899 | $4,582,332 | 0 | $0 | 0 | $0 |
| 2024-03 | 1,000,000 | $200,000 | 0 | $0 | 1,364,666 | $272,933 |
| 2023-09 | 100,000 | $22,000 | 0 | $0 | 0 | $0 |
| 2023-06 | 95,983 | $16,125 | 0 | $0 | 0 | $0 |
| 2022-08 | 200,000 | $56,000 | 0 | $0 | 0 | $0 |
| 2022-06 | 25,000 | $9,500 | 0 | $0 | 0 | $0 |
| 2022-05 | 32,072,237 | $13,601,350 | 0 | $0 | 0 | $0 |
| 2021-11 | 1,378,757 | $1,015,654 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 0 | $0 | 40,000 | $0 |
| 2021-01 | 0 | $0 | 12,559,109 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 40,000 | $0 |
| 2020-09 | 1,707,277 | $560,649 | 0 | $0 | 0 | $0 |
| 2020-07 | 2,192,997 | $548,248 | 23,820,765 | $5,240,568 | 0 | $0 |
| 2019-12 | 119,519 | $23,903 | 0 | $0 | 0 | $0 |
| 2019-11 | 2,806,097 | $549,546 | 3,439,866 | $619,175 | 25,000 | $0 |
| 2019-09 | 3,581,366 | $680,458 | 0 | $0 | 0 | $0 |
| 2019-05 | 0 | $0 | 0 | $0 | 73,334 | $0 |
| 2019-03 | 276,151 | $57,991 | 0 | $0 | 0 | $0 |
| 2019-02 | 0 | $0 | 0 | $0 | 210,000 | $0 |
| 2018-12 | 1,500,000 | $315,000 | 0 | $0 | 0 | $0 |
| 2018-11 | 0 | $0 | 0 | $0 | 50,000 | $0 |
| 2018-10 | 100,000 | $23,000 | 0 | $0 | 0 | $0 |
| 2018-05 | 937,745 | $221,909 | 0 | $0 | 0 | $0 |
| 2018-03 | 100,000 | $20,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-27 | Coleman Craig E. | Buy | 1,421,293 | .11 | 156,342 |
| 2024-05-01 | Coleman Craig E. | Buy | 29,506,606 | .15 | 4,425,990 |
| 2024-03-25 | Sharman John Stewart (Chief Executive Officer) | Option Ex | 1,364,666 | .20 | 272,933 |
| 2024-03-25 | Coleman Craig E. | Buy | 1,000,000 | .20 | 200,000 |
| 2023-09-11 | Coleman Craig E. | Buy | 100,000 | .22 | 22,000 |
| 2023-06-30 | Hoey David L (Director) | Buy | 95,983 | .17 | 16,125 |
| 2022-08-17 | Coleman Craig E. | Buy | 200,000 | .28 | 56,000 |
| 2022-06-09 | Coleman Craig E. (Director) | Buy | 25,000 | .38 | 9,500 |
| 2022-05-27 | Coleman Craig E. (Director) | Buy | 32,023,617 | .42 | 13,578,013 |
| 2022-05-24 | Coleman Craig E. (Director) | Buy | 48,620 | .48 | 23,337 |
| 2021-11-05 | Coleman Craig E. | Buy | 329,613 | .75 | 246,880 |
| 2021-11-03 | Coleman Craig E. | Buy | 152,638 | .75 | 114,325 |
| 2021-11-01 | Coleman Craig E. | Buy | 896,506 | .73 | 654,449 |
| 2021-08-19 | Balak Salesh (Chief Financial Officer) | Option Ex | 40,000 | .00 | 0 |
| 2021-01-07 | Coleman Craig E. | Sale | 12,559,109 | .00 | 0 |
| 2020-12-11 | Balak Salesh (Chief Financial Officer) | Option Ex | 40,000 | .00 | 0 |
| 2020-09-15 | Coleman Craig E. | Buy | 784,687 | .34 | 266,793 |
| 2020-09-14 | Coleman Craig E. | Buy | 80,178 | .33 | 26,458 |
| 2020-09-10 | Coleman Craig E. | Buy | 135,135 | .33 | 43,918 |
| 2020-09-07 | Coleman Craig E. | Buy | 322,315 | .33 | 104,752 |
| 2020-09-04 | Coleman Craig E. | Buy | 284,962 | .30 | 86,628 |
| 2020-09-03 | Coleman Craig E. | Buy | 100,000 | .32 | 32,100 |
| 2020-07-27 | Vf High Conviction Fund | Buy | 730,999 | .25 | 182,749 |
| 2020-07-27 | Coleman Craig E. | Buy | 1,461,998 | .25 | 365,499 |
| 2020-07-07 | Cvc Ltd | Sale | 23,820,765 | .22 | 5,240,568 |
| 2019-12-02 | Coleman Craig E. | Buy | 119,519 | .20 | 23,903 |
| 2019-11-28 | Coleman Craig E. | Buy | 1,885,217 | .20 | 377,043 |
| 2019-11-27 | Coleman Craig E. | Buy | 214,783 | .19 | 41,023 |
| 2019-11-15 | Coleman Craig E. | Buy | 36,500 | .19 | 6,935 |
| 2019-11-13 | Coleman Craig E. | Buy | 669,597 | .19 | 124,545 |
| 2019-11-12 | Balak Salesh (See Remarks) | Option Ex | 25,000 | .00 | 0 |
| 2019-11-01 | Vf Strategic Equities Fund | Sale | 3,439,866 | .18 | 619,175 |
| 2019-09-12 | Vf Strategic Equities Fund | Buy | 80,000 | .19 | 15,200 |
| 2019-09-12 | Coleman Craig E. | Buy | 80,000 | .19 | 15,200 |
| 2019-09-11 | Vf Strategic Equities Fund | Buy | 1,710,683 | .19 | 325,029 |
| 2019-09-11 | Coleman Craig E. | Buy | 1,710,683 | .19 | 325,029 |
| 2019-05-29 | Balak Salesh (Chief Financial Officer) | Option Ex | 73,334 | .00 | 0 |
| 2019-03-05 | Cvc Ltd | Buy | 176,151 | .21 | 36,991 |
| 2019-03-01 | Cvc Ltd | Buy | 100,000 | .21 | 21,000 |
| 2019-02-28 | Oates Adrian (See Remarks) | Option Ex | 210,000 | .00 | 0 |
| 2018-12-04 | Cvc Ltd | Buy | 1,500,000 | .21 | 315,000 |
| 2018-11-16 | Oates Adrian (See Remarks) | Option Ex | 25,000 | .00 | 0 |
| 2018-11-16 | Balak Salesh (Chief Financial Officer) | Option Ex | 25,000 | .00 | 0 |
| 2018-10-11 | Cvc Ltd | Buy | 100,000 | .23 | 23,000 |
| 2018-05-09 | Vf High Conviction Fund | Buy | 66,584 | .24 | 15,980 |
| 2018-05-09 | Coleman Craig E. | Buy | 66,584 | .24 | 15,980 |
| 2018-05-07 | Vf High Conviction Fund | Buy | 198,640 | .23 | 46,084 |
| 2018-05-07 | Coleman Craig E. | Buy | 198,640 | .23 | 46,084 |
| 2018-05-04 | Legleiter Rick L (Chief Executive Officer) | Buy | 158,687 | .26 | 41,099 |
| 2018-05-03 | Vf High Conviction Fund | Buy | 124,305 | .23 | 28,341 |
| 2018-05-03 | Coleman Craig E. | Buy | 124,305 | .23 | 28,341 |
| 2018-03-15 | Hoey David L (Director) | Buy | 100,000 | .20 | 20,500 |
| 2018-02-01 | Hoey David L (Director) | Buy | 116,414 | .23 | 26,775 |
| 2017-12-29 | Vf Strategic Equities Fund | Buy | 2,250,953 | .30 | 675,285 |
| 2017-12-29 | Vf High Conviction Fund | Buy | 750,318 | .30 | 225,095 |
| 2017-12-29 | Coleman Craig E. | Buy | 3,001,271 | .30 | 900,381 |
| 2017-12-28 | Vf Strategic Equities Fund | Buy | 151,124 | .29 | 44,430 |
| 2017-12-28 | Vf High Conviction Fund | Buy | 50,374 | .29 | 14,809 |
| 2017-12-28 | Coleman Craig E. | Buy | 201,498 | .29 | 59,240 |
| 2017-12-27 | Vf Strategic Equities Fund | Buy | 168,737 | .29 | 48,764 |
| 2017-12-27 | Vf High Conviction Fund | Buy | 56,245 | .29 | 16,254 |
| 2017-12-27 | Coleman Craig E. | Buy | 224,982 | .29 | 65,019 |
| 2017-12-22 | Vf Strategic Equities Fund | Buy | 100,838 | .27 | 27,125 |
| 2017-12-22 | Vf High Conviction Fund | Buy | 33,613 | .27 | 9,041 |
| 2017-12-22 | Coleman Craig E. | Buy | 134,451 | .27 | 36,167 |
| 2017-10-24 | Chambers Garry (VP Technology Development) | Option Ex | 25,000 | .00 | 0 |
| 2017-10-24 | Balak Salesh (Chief Financial Officer) | Option Ex | 16,667 | .00 | 0 |
| 2017-10-24 | Hodges Alastair (Chief Scientist) | Option Ex | 25,000 | .00 | 0 |
| 2017-08-16 | Oates Adrian (See Remarks) | Option Ex | 41,667 | .00 | 0 |
| 2017-03-01 | Vf High Conviction Fund | Buy | 32,988 | .38 | 12,535 |
| 2017-03-01 | Coleman Craig E. | Buy | 32,988 | .38 | 12,535 |
| 2017-02-28 | Vf High Conviction Fund | Buy | 247,001 | .39 | 95,095 |
| 2017-02-28 | Coleman Craig E. | Buy | 247,001 | .39 | 95,095 |
| 2017-02-27 | Vf High Conviction Fund | Buy | 402,924 | .38 | 153,916 |
| 2017-02-27 | Coleman Craig E. | Buy | 402,924 | .38 | 153,916 |
| 2017-02-14 | Vf High Conviction Fund | Buy | 7,782 | .34 | 2,645 |
| 2017-02-14 | Coleman Craig E. | Buy | 7,782 | .34 | 2,645 |
| 2016-12-06 | Vf High Conviction Fund | Buy | 16,078 | .34 | 5,386 |
| 2016-12-06 | Coleman Craig E. | Buy | 16,078 | .34 | 5,386 |
| 2016-09-28 | Hoey David L (Director) | Buy | 150,000 | .29 | 43,500 |
| 2016-06-10 | Hoey David L (Director) | Buy | 200,000 | .29 | 57,999 |
| 2015-12-31 | Hodges Alastair (Chief Scientist) | Option Ex | 36,248 | .26 | 9,424 |
| 2015-12-16 | Chambers Garry (Vice President, Operations) | Sale | 100,000 | .45 | 45,000 |
| 2015-02-26 | Wright Paul (Chief Executive Officer) | Buy | 269,088 | 99,812.57 | 26,858,364,836 |
| 2014-05-15 | Denver Andrew (Director) | Buy | 50,000 | 7,670.00 | 383,500,000 |
| 2014-05-14 | Hanley Denis (Director) | Buy | 50,000 | 8,127.90 | 406,395,000 |
| 2014-05-14 | Denver Andrew (Director) | Buy | 50,000 | 8,940.00 | 447,000,000 |
| 2014-05-13 | Denver Andrew (Director) | Buy | 50,000 | 11,500.00 | 575,000,000 |
| 2014-05-12 | Denver Andrew (Director) | Buy | 30,000 | 6,610.50 | 198,315,000 |
| 2014-05-06 | Smith Christopher M (Director) | Buy | 30,000 | 11,249.95 | 337,498,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of UBI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Universal Biosensors Inc (symbol UBI, CIK number 1279695) see the Securities and Exchange Commission (SEC) website.